Bluejay Diagnostics Inc
NASDAQ:BJDX

Watchlist Manager
Bluejay Diagnostics Inc Logo
Bluejay Diagnostics Inc
NASDAQ:BJDX
Watchlist
Price: 0.58 USD 0.87% Market Closed
Updated: May 19, 2024

Bluejay Diagnostics Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bluejay Diagnostics Inc
Cost of Revenue Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Bluejay Diagnostics Inc
NASDAQ:BJDX
Cost of Revenue
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Cost of Revenue
-$11.6B
CAGR 3-Years
-7%
CAGR 5-Years
-5%
CAGR 10-Years
-11%
Boston Scientific Corp
NYSE:BSX
Cost of Revenue
-$4.5B
CAGR 3-Years
-8%
CAGR 5-Years
-9%
CAGR 10-Years
-7%
Stryker Corp
NYSE:SYK
Cost of Revenue
-$7.5B
CAGR 3-Years
-11%
CAGR 5-Years
-10%
CAGR 10-Years
-10%
Abbott Laboratories
NYSE:ABT
Cost of Revenue
-$18B
CAGR 3-Years
-4%
CAGR 5-Years
-7%
CAGR 10-Years
-7%
Intuitive Surgical Inc
NASDAQ:ISRG
Cost of Revenue
-$2.5B
CAGR 3-Years
-17%
CAGR 5-Years
-16%
CAGR 10-Years
-14%

See Also

What is Bluejay Diagnostics Inc's Cost of Revenue?
Cost of Revenue
0 USD

Based on the financial report for Dec 31, 2023, Bluejay Diagnostics Inc's Cost of Revenue amounts to 0 USD.